Livestock Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Veröffentlicht von: pbi
Veröffentlicht am: 20.02.2018 14:12
Rubrik: Recht & Politik

(Presseportal openBroadcast) - Market Outline: Livestock Pharmaceuticals Market
Livestock pharmaceuticals are used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed.

Market Dynamics: Livestock Pharmaceuticals Market
Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the livestock pharmaceuticals market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of livestock pharmaceuticals market.

A sample of this report is available upon request @

Market Scope: Livestock Pharmaceuticals Market
Livestock pharmaceuticals market is segmented on the basis of drug class, disease type, route of administration, livestock type, and distribution channel
Based on the drug class, livestock pharmaceuticals is segmented into the following:
• Vaccines
• Antivirals
• Antibiotics
• Parasiticides
• Anti-inflammatory drugs
• Others
Based on the disease type, livestock pharmaceuticals market is segmented into the following:
• Neurological disorders
• Infectious diseases
• Viral diseases
• Bacterial diseases
• Fungal diseases
• Others
Based on the route of administration, livestock pharmaceuticals market is segmented into the following:
• Oral
• Parenteral
• Topical
• Others
Based on the livestock, livestock pharmaceutical market is segmented into the following:
• Poultry
• Aquatic Animals
• Swine
• Equine
• Sheep
• Cattle
• Others
Based on the distribution channel, livestock pharmaceuticals market is segmented into the following:
• Veterinary hospitals
• Veterinary pharmacies
• online pharmacies

To view TOC of this report is available upon request @

Market Summary: Livestock Pharmaceuticals Market
Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

Regional Analysis: Livestock Pharmaceuticals Market
Geographically, livestock pharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Increase in the R&D activities for the development of newer drugs by several U.S. pharmaceutical companies, rise in awareness about the veterinary diseases and treatment, increase in the animal welfare expenditure, and rise in product approvals for livestock diseases are anticipated to propel the North America livestock pharmaceuticals market. Europe livestock pharmaceuticals marketgrowth driven by rise in the production of aquatic animals in Norway, Denmark, Ireland, and other European countries, increase in the demand for healthy meat and other livestock products, rise in the disposable income, and increase in the prevalence of zoonotic diseases. However, Asia Pacific livestock pharmaceuticals market growing at significant rate owing to increase in population demanding for quality meat, launching of newer drugs in Asia Pacific region, and industrialization of poultry sector in the region.

Need more information about this report @

Market Participants: Livestock Pharmaceuticals Market
Some of the players in livestock pharmaceuticals market are Merck Animal Health (U.S.), Zoetis Inc. (Pfizer) (U.S.), Boehringer Ingelheim (Germany), Ceva Animal Health (France), Bayer Animal Health (Germany), Virbac Inc. (France), Elanco Animal Health (U.S.), Eco Animal Health (U.K.), and Heska Corporation (U.S.) to name a few.

Notable Market Developments: Livestock Pharmaceuticals Market
• In July 2017, ECO Animal Health received FDA approval for Aivlosin an antibiotic used in the treatment of major enteric and respiratory diseases in poultry and swine
• In March 2017, Merck Animal Health acquired Brazilian company Vallee S.A. for strengthening its livestock pharmaceuticals product portfolio

Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @



Toll Free (US): +1-866-598-1553
Website @

Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.